Loading
Preparing the next Annolyse view.
Company archive
Each company archive keeps the publication history in release order, with the newest Annolyse briefing first.
Archive navigation
Company and sector routes have dedicated HTML, while the archive stays ordered by publication date.
Showing 1-8 of 8 published briefings.
Earnings growth is genuine but meaningfully flattered by a non-recurring PY shareholder-dispute legal cost and a lower effective tax rate, not by...
Published 22 April 2026
Read briefingAn 8% revenue decline flowed into materially worse cash conversion and a halved cash balance, with legal costs flagged but not quantified.
Published 22 April 2026
Read briefingA $0.2m shareholder-litigation defence and a sharp drop in cash conversion dragged both earnings and the cash buffer despite broadly flat revenue.
Published 22 April 2026
Read briefingStrongest profit since 2007 listing is real, but operating cash flow fell 5% even as EBITDA rose 9.5%, and the result remains a single-country story.
Published 22 April 2026
Read briefingPBT grew 12.8% on stronger non-operating income, yet NPAT advanced only 5.2% after the effective tax rate stepped up from 26% to 31%.
Published 22 April 2026
Read briefingRevenue rose 18.4% and PBT 68.3%, but HY23 delivered 61% of full-year NPAT, implying a materially softer H2 on profit.
Published 21 April 2026
Read briefingRoyalty-led recovery and strong cash conversion lift the interim result, while FY22 seasonality warns that nearly all profit tends to land in H1.
Published 22 April 2026
Read briefingRoyalty-driven New Zealand recovery delivers strong operating leverage, offset by a small international operation now losing roughly nine times...
Published 21 April 2026
Read briefingEmail updates
Get full analytical briefings by email as new coverage is published.